Plus, news about Seres Therapeutics, Nestlé Health Science, Pfizer, Evotec and Relay Therapeutics:
FDA lifts partial hold on Stoke Therapeutics’ Dravet syndrome drug: …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is already upon us.
A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.
As expected, the FDA approved the Paradise ultrasound renal denervation system as an adjunctive treatment for hypertension, giving patients another option to control their blood